Cite
HARVARD Citation
Mcmaster, C. et al. (n.d.). FRI0602 SERUM ALBUMIN PREDICTS ONCOLOGICAL OUTCOMES BUT NOT RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FOLLOWING PD-1 INHIBITOR THERAPY. Annals of the rheumatic diseases. pp. 996-997. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mcmaster, C. et al. (n.d.). FRI0602 SERUM ALBUMIN PREDICTS ONCOLOGICAL OUTCOMES BUT NOT RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FOLLOWING PD-1 INHIBITOR THERAPY. Annals of the rheumatic diseases. pp. 996-997. [Online].